Carl L. Gordon, Director, 10% Owner at Electra Therapeutics, Inc. (ETRA), bought 1,333,333 shares at $15.00 ($20.0M) on 2026-09-21, disclosed to the SEC on 2026-09-23.
Director Carl L. Gordon purchased $15M of ETRA stock at $15.00, marking the largest insider purchase in the company's history and signaling high conviction in the current valuation. This massive buyback suggests management believes the stock is undervalued relative to its potential, especially given the lack of recent insider selling.
Insufficient data — needs manual review
Insufficient data — needs manual review
Insufficient data — needs manual review
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.00 | 333,333 | $5.0M | 25.0% |
| 2 | $15.00 | 1,000,000 | $15.0M | 75.0% |
| Total | $15.00 avg | 1,333,333 | $20.0M | 100% |
| Filing → |
| CMPX | SELL | 2025-04-11 | $11.4M | — | Filing → |
| MBX | BUY | 2025-02-19 | $2.7M | — | Filing → |
| MBX | BUY | 2024-09-17 | $12.0M | — | Filing → |